LENZ Therapeutics (LENZ) Preferred Shares Issued (2020 - 2023)

LENZ Therapeutics (LENZ) has 3 years of Preferred Shares Issued data on file, last reported at $17.0 million in Q2 2023.

• Preferred Shares Issued for Q2 2023 came in at $17.0 million, changed N/A year-over-year; the trailing twelve-month figure through Mar 2024 was $17.0 million (down 74.28% YoY), and the FY2023 annual result was $83.0 million, changed N/A from the prior year.
• Preferred Shares Issued retreated to $17.0 million in Q2 2023 per LENZ's latest filing, from $66.0 million in the prior quarter.
• Over five years, Preferred Shares Issued peaked at $150.7 million in Q1 2021 and troughed at $10.0 million in Q2 2020.
• A 3-year average of $45.6 million and a median of $16.0 million in 2020 frame the typical range for Preferred Shares Issued.
• On a YoY basis, Preferred Shares Issued climbed as much as 48.21% in 2021 and fell as far as 48.21% in 2021.
• A 3-year view of Preferred Shares Issued shows it stood at $15.0 million in 2020, then fell by 1.19% to $14.8 million in 2021, then gained by 14.54% to $17.0 million in 2023.
• Business Quant data shows LENZ's Preferred Shares Issued at $17.0 million in Q2 2023, $66.0 million in Q1 2023, and $14.8 million in Q2 2021.